Physician profile
Christopher G Borders
NPI 1922355825
$3,194.99
in general payments reported to CMS, 2019-2025
31 companies · $801 in 2025
The $801 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $276 · 2022: $773 · 2023: $523 · 2024: $822 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,076 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,076.33 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $437.75 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $338.49 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $327.84 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $314.95 | 2023-2025 | Repatha, Otezla, Repatha |
| Astellas Pharma US INC | $236.46 | 2021-2025 | Veozah |
| Glaxosmithkline, LLC. | $196.94 | 2021-2025 | Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $139.71 | 2022-2025 | |
| Nevro Corp. | $134.44 | 2022-2023 | Senza |
| Teva Pharmaceuticals USA, INC. | $121.91 | 2022 | |
| Pfizer INC. | $120.06 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.91 | 2022-2025 | Jardiance, Ofev |
| Xeris Pharmaceuticals, INC. | $92.48 | 2023-2025 | Gvoke Hypopen |
| Lundbeck LLC | $78.00 | 2021-2025 | Vyepti |
| Sanofi-Aventis U.S. LLC | $70.40 | 2022 | |
| Inspire Medical Systems, INC. | $65.93 | 2023 | Inspire |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $57.92 | 2024-2025 | Cologuard Collection Kit |
| Dynavax Technologies Corporation | $50.78 | 2023-2024 | Heplisav-B |
| Seqirus USA INC | $34.86 | 2022-2024 | Fluad, Flucelvax |
| Merck Sharp & Dohme LLC | $30.10 | 2024-2025 | Capvaxive, Gardasil 9, Vaxneuvance |
| Medtronic, INC. | $29.09 | 2022-2024 | Intellis Adaptivestim |
| Genentech USA, INC. | $28.63 | 2021 | |
| Dexcom, INC. | $25.83 | 2023 | Dexcom G6 Transmitter |
| Abbvie INC. | $22.03 | 2023 | |
| Daiichi Sankyo INC. | $18.23 | 2024 | Injectafer |
| Biohaven Pharmaceutical Holding Company LTD. | $17.41 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $16.58 | 2022 | |
| Baxter Healthcare | $15.00 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Jazz Pharmaceuticals INC. | $14.89 | 2021 | |
| Boston Scientific Corporation | $14.68 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.20 | 2024 | Caplyta |
| Novartis Pharmaceuticals Corporation | $13.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Borders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.